SGX Stock Plummets After Troxatyl Fails In Phase II/III Aug. 30, 2006 By Aaron Lorenzo No Comments Shares in SGX Pharmaceuticals Inc. suffered mightily on Tuesday following a Phase II/III study stoppage. (BioWorld Today)Read More
SGX Stock Plummets After Troxatyl Fails In Phase II/III Aug. 30, 2006 By Aaron Lorenzo No Comments Shares in SGX Pharmaceuticals Inc. suffered mightily on Tuesday following a Phase II/III study stoppage. (BioWorld Today)Read More
EPIX's Contrast Agent Vasovist Dealt Another Setback By FDA Aug. 29, 2006 By Aaron Lorenzo No Comments
EPIX's Contrast Agent Vasovist Dealt Another Setback By FDA Aug. 29, 2006 By Aaron Lorenzo No Comments
Biotechs Should Benefit When Leadership Atop FDA Finalized Aug. 18, 2006 By Aaron Lorenzo No Comments
Biotechs Should Benefit When Leadership Atop FDA Finalized Aug. 18, 2006 By Aaron Lorenzo No Comments
